Curis Company
Curis develops Erivedge, a capsule manufactured for the treatment of adults with skin cancer.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2000
Employees Number:
11-50
Funding Status:
IPO
Total Funding:
69000000
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership